In vivo immunostimulatory effects of CpG ODN in newborn piglets

Molecular Immunology

Volumn 44, Issue 6, 2007, Pages 1238-1244

  Linghua, Zhang ^a   Xingshan, Tian ^b   Fengzhen, Zhou ^b  

^a SOUTH CHINA AGRICULTURAL UNIVERSITY   (China)

^b INSTITUTE OF ANIMAL SCIENCE   (China)

Author keywords

CpG ODN; Immune response; The newborn piglets

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; EMULSIFYING AGENT; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PHOSPHATE BUFFERED SALINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG EFFECT; DRUG FORMULATION; IMMUNOSTIMULATION; IN VIVO STUDY; INJECTION; INNATE IMMUNITY; INOCULATION; LYMPHOCYTE SUBPOPULATION; MOLECULAR STABILITY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SERUM; SWINE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANIMALS, NEWBORN; CATTLE; CD4-CD8 RATIO; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CPG ISLANDS; FEMALE; MICE; OLIGODEOXYRIBONUCLEOTIDES; SWINE;

ANIMALIA; OVIS ARIES;

EID: 33748961884     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2006.05.016     Document Type: Article

References (52)

1. Agrawal S., and Kandimalla E.R. Medicinal chemistry and therapeutic potential of CpG DNA. Trends Mol. Med. 8 (2002) 114-121
2. Alcon V.L., Foldvari M., Snider M., Willson P., Gomis S., and Hecker R. Induction of protective immunity in pigs after immunization with CpG oligodeoxynucleotides formulated in a lipid-based delivery system (Biphasix™). Vaccine 21 (2003) 1811-1814
3. Ashkar A.A., Bauer S., Mitchell W.J., Vieira J., and Rosenthal K.L. Local delivery of CpG oligodeoxynucleotides induces rapid changes in the genital mucosa and inhibits replication, but not entry, of herpes simplex virus type 2. J. Virol. 77 16 (2003) 8948-8956
4. Ballas Z.K., Rasmussen W.L., and Krieg A.M. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J. Immunol. 157 (1996) 1840-1845
5. Blalock J.E. A molecular basis for bidirectional communication between the immune and neuroendocrine systems. Physiol. Rev. 69 1 (1989) 1-32
6. Chu R.S., Targoni O.S., Krieg A.M., Lehmann P.V., and Harding C.V. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J. Exp. Med. 186 10 (1997) 1623-1631
7. Davis H.L., Weeratna R., Waldschmidt T.J., Tygrett L., Schorr J., Krieg A.M., and Weeranta R. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J. Immunol. 160 2 (1998) 870-876
8. Elkins K.L., Rhinehart-Jones T.R., Stibitz S., Conover J.S., and Klinman D.M. Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria. J. Immunol. 162 4 (1999) 2291-2298
9. Gomis S., Babiuk L., Godson D.L., Allan B., Thrush T., Townsend H., Willson P., Waters E., Hecker R., and Potter A. Protection of chickens against Escherichia coli infections by DNA containing CpG motifs. Infect. Immun. 71 2 (2003) 857-863
10. Gramzinski R.A., Doolan D.L., Sedegah M., Davis H.L., Krieg A.M., and Hoffman S.L. Interleukin-12- and gamma interferon-dependent protection against malaria conferred by CpG oligodeoxynucleotide in mice. Infect. Immun. 69 3 (2001) 643-1649
11. Harandi A.M., Eriksson K., and Holmgren J. A protective role of locally administered immunostimulatory CpG oligodeoxynucleotide in a mouse model of genital herpes infection. J. Virol. 77 2 (2003) 953-962
12. Hartmann G., Weeratna R.D., Ballas Z.K., Payette P., Blackwell S., and Suparto I. Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo. J. Immunol. 164 (2000) 1617-1624
13. Hasslung F.C., Berg M., Allan G.M., Meehan B.M., McNeilly F., and Fossum C. Identification of a sequence from the genome of porcine circovirus type 2 with an inhibitory effect on INF-alpha production by porcine PBMCs. Gen. Virol. 84 (2003) 2937-2945
14. Ioannou X.P., Gomis S.M., Karvonen B., Hecker R., Babiuk L.A., and van Drunen Littel-van den Hurk S. CpG-containing oligodeoxynucleotides, in combination with conventional adjuvants, enhance the magnitude and change the bias of the immune responses to a herpesvirus glycoprotein. Vaccine 21 1/2 (2002) 127-137
15. Ioannou X.P., Griebel P., Hecker R., Babiuk L.A., and van Drunen Littel-van den Hurk S. The immunogenicity and protective efficacy of bovine herpesvirus 1 glycoprotein D plus emulsigen are increased by formulation with CpG oligodeoxynucleotides. J. Virol. 76 18 (2002) 9002-9010
16. Juffermans N.P., Leemans J.C., Florquin S., Verbon A., Kolk A.H., Speelman P., van Deventer S.J., and van der Poll T. CpG oligodeoxynucleotides enhance host defense during murine tuberculosis. Infect. Immun. 70 1 (2002) 147-152
17. Kamstrup S., Daniela V., and Dennis M.K. Response of porcine peripheral blood mononuclear cells to CpG-containing oligodeoxynucleotides. Vet. Microbiol. 78 4 (2001) 353-362
18. Kelly C.R., Kopf J.D., and Zimmerman D.R. Characterization of antral follicle populations during the estrous cycle in pigs selected for ovulation rate. J. Anim. Sci. 66 5 (1988) 1230-1235
19. Klinman D.M., Barnhart K.M., and Conover J. CpG motifs as immune adjuvants. Vaccine 17 1 (1999) 19-25
20. Krieg A.M., Yi A., Matson S., Waldschmidt T.J., Bishop G.A., Teasdale R., Koretzky G.A., and Klinman D.M. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374 (1995) 546-548
21. Krieg A.M., Love-Homan L., Yi A.K., and Harty J.T. CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge. J. Immunol. 161 5 (1998) 2428-2434
22. Krieg A.M., Yi A.K., and Hartmann G. Mechanisms and therapeutic applications of immune stimulatory CpG DNA. Pharmacol. Ther. 84 (1999) 113-120
23. Krieg A.M. CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20 (2002) 709-760
24. Lipford G.B., Sparwasser T., Bauer M., Zimmerman S., Koch E.S., Heeg K., and Wagner H. Immunostimulatory DNA: sequence-dependent production of potentially harmful or useful cytokines. Eur. J. Immunol. 27 (1997) 3420-3426
25. Lunney J.K., and Pescovitz M.D. Phenotypic and functional characterization of pig lymphocyte populations. Vet. Immunol. Immunopathol. 17 (1987) 125-144
26. Masuda K., Sakaguchi M., Saito S., Deboer D.J., Fujiwara S., Kurata K., Yamashita K., Hasegawa A., Ohno K., and Tsujimoto H. In vivo and in vitro tests showing sensitization to Japanese cedar (Cryptomeria japonica) pollen allergen in atopic dogs. J. Vet. Med. Sci. 62 (2000) 995-1000
27. Mena A., Nichani A.K., Popowych Y., Ioannou X.P., Godson D.L., Mutwiri G.K., Hecker R., Babiuk L.A., and Griebel P. Bovine and ovine blood mononuclear leukocytes differ markedly in innate immune responses induced by class A and class B CpG oligodeoxynucleotide. Oligonucleotides 13 4 (2003) 245-259
28. Mena A., Nichani A.K., Popowych Y., Godson D.L., Dent D., Townsend H.G.G., Mutwiri G.K., Hecker R., Babiuk L.A., and Griebel P. Innate immune responses induced by CpG oligodeoxyribonucleotide stimulation of ovine blood mononuclear cells. Immunology 110 (2003) 250-257
29. Messina J.P., Gilkeson G.S., and Pisetsky D.S. Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA. J. Immunol. 147 (1991) 1759-1764
30. Mutwiri G., Pontarollo R., Babiuk S., Griebel P., van Drunen Littel-van den Hurk S., and Mena A. Biological activity of immunostimulatory CpG DNA motifs in domestic animals. Vet. Immunol. Immunopathol. 91 (2003) 89-103
31. Nichani A.K., Mena A., Popowych Y., Dent D., Townsend H.G.G., Mutwiri G.K., Hecker R., Babiuk L.A., and Griebel P. In vivo immunostimulatory effects of CpG oligodeoxynucleotide in cattle and sheep. Vet. Immunol. Immunopathol. 98 1/2 (2004) 17-29
32. Olbrich A.R., Schimmer S., Heeg K., Schepers K., Schumacher T.N., and Dittmer U. Effective postexposure treatment of retrovirus-induced disease with immunostimulatory DNA containing CpG motifs. J. Virol. 76 22 (2002) 11397-11404
33. Philip J.H., Keith J.J., Rolf H., Glyn H., and Mark A.C. Evaluation of adjuvants for protein vaccines against tuberculosis in guinea pigs. Vaccine 21 (2003) 977-982
34. Pisetsky D.S. Mechanisms of immune stimulation by bacterial DNA. Springer Semin. Immunopathol. 22 (2000) 21-33
35. Rankin R., Pontarollo R., Gomis S.M., Karvonen B., Willson P., and Loehr B.I. CpG containing oligodeoxynucleotides augment and switch immune responses of cattle to bovine herpesvirus-1. Vaccine 20 (2002) 3014-3022
36. Saalmuller A., Weiland F., and Reddehase M.J. Resting porcine T-lymphocytes expressing class II major histocompatibility antigen. Immunobiology 183 (1991) 102-114
37. Scheule R.K. The role of CpG motifs in immunostimulation and gene therapy. Adv. Drug. Deliv. Rev. 44 (2000) 119-134
38. Sparwasser T., Miethke T., Lipford G., Erdmann A., Hacker H., Heeg K., and Wagner H. Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor-alpha-mediated shock. Eur. J. Immunol. 27 (1997) 1671-1679
39. Sparwasser T., Miethke T., Lipford G., Borschert K., Hacker H., Heeg K., and Wagner H. Bacterial DNA causes septic shock. Nature 386 (1997) 336-337
40. Sparwasser T., Koch E., Vabulas R.M., Heeg K., Lipford G.B., Ellwart J.W., and Wager H. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur. J. Immunol. 28 (1998) 2045-2054
41. Stacey K.J., Sweet M.J., and Hume D.A. Macrophages ingest and are activated by bacterial DNA. J. Immunol. 157 (1996) 2116-2122
42. Stacey K.J., and Blackwell J.M. Immunostimulatory DNA as an adjuvant in vaccination against Leishmania major. Infect. Immun. 67 8 (1999) 3719-3726
43. Tokunaga T., Yano O., Kuramoto E., Kimura Y., Yamamoto T., Kataoka T., and Yamamoto S. Synthetic oligonucleotides with particular base sequences from the cDNA encoding proteins of Mycobacterium bovis BCG induce interferons and activate natural killer cells. Microbiol. Immunol. 36 (1992) 55-66
44. Van der Stede Y., Verdonck F., Vancaeneghem S., Cox E., and Goddeeris B.M. CpG oligodinucleotides as an effective adjuvant in pigs for intramuscular immunizations. Vet. Immunol. Immunopathol. 86 (2002) 31-41
45. Verthelyi D., Gursel M., Kenney R.T., Lifson J.D., Liu S., Mican J., and Klinman D.M. CpG oligodeoxynucleotides protect normal and SIV-infected macaques from Leishmania infection. J. Immunol. 170 9 (2003) 4717-4723
46. Walker P.S., Scharton-Kersten T., Krieg A.M., Love-Homan L., Rowton E.D., Udey M.C., and Vogel J.C. Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12- and IFN-gamma-dependent mechanisms. Proc. Natl. Acad. Sci. U.S.A. 96 12 (1999) 6970-6975
47. Yamamoto S., Yamamoto T., Kataoka T., Kuramoto E., Yano O., and Tokunaga T. Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN and augment IFN mediated natural killer activity. J. Immunol. 148 (1992) 4072-4076
48. Yvonne J.R., Arthur O.A., and Reinhard P. HIV-induced decline in blood CD4/CD8 ratios: viral killing or altered lymphocyte trafficking?. Immunol. Today 19 1 (1998) 10-16
49. Zhang L.H., Tian X.S., Guo Y., and Zhou F.Z. The effect of transgenic expression of porcine interleukin-6 gene and CpG sequences on immune responses of the newborn piglets inoculated with pseudorabies attenuated vaccine. Res. Vet. Sci. 80 (2006) 281-286
50. + T subpopulations in the immune response to porcine reproductive and respiratory syndrome killed virus vaccine. Vaccine 24 11 (2006) 1874-1879
51. Zhang L.H., Guo Y., Tian X.S., and Zhou F.Z. Co-administration of porcine-specific CpG oligodeoxynucleotide enhances the immune responses to pseudorabies attenuated virus vaccine in newborn piglets in vivo. Develop. Comp. Immunol. 30 6 (2006) 589-596
52. Zimmermann S., Egeter O., Hausmann S., Lipford G.B., Rocken M., Wagner H., and Heeg K. CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis. J. Immunol. 160 8 (1998) 3627-3630